Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Needham & Company LLC restated their buy rating on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Rating) in a research note issued to investors on Thursday morning, Benzinga reports. The firm currently has a $14.00 price target on the biotechnology company’s stock. BCRX has been the topic of a number of other research reports. JMP […]
Fisher Asset Management LLC cut its holdings in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) by 14.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 4,431,114 shares of the biotechnology company’s stock after selling 732,731 shares during the period. Fisher Asset Management LLC’s holdings in BioCryst Pharmaceuticals were worth $50,869,000 at the […]
BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Rating) had its price objective reduced by Evercore ISI from $13.00 to $10.00 in a report released on Thursday morning, The Fly reports. They currently have an outperform rating on the biotechnology company’s stock. Several other brokerages also recently issued reports on BCRX. Royal Bank of Canada reiterated a sector […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month target price […]